VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
IKTInhibikase Therapeutics, Inc.$1.67$119M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksIKTPrice History

IKT logoInhibikase Therapeutics, Inc. (IKT) Stock Price History

Historical prices from 2020 to 2026

$1.67+0.01  (+0.60%)close Jun 11
Returns
1M
-17.7%
3M
-17.3%
YTD
-14.4%
1Y
-14.8%
3Y
-26.0%
5Y
-45.8%
ATH$70.80Dec 2020-97.6%
ATL$0.79Oct 2023pre-split
Avg Vol (50D)795K/ day
52-Week Range$1.33 — $2.26
LowCurrent: $1.67High

Loading 10-year price history...

IKT Historical Performance

1 YearTotal Return
-14.8%
Price: -14.8%
3 YearsTotal Return
-59.5%
CAGR: -26.0%
Price: -59.5%
5 YearsTotal Return
-95.3%
CAGR: -45.8%
Price: -95.3%
YTD
-14.4%

IKT Annual Returns

Year-by-year price performance · 2020–2026

Best+144.4%2024
Worst-78.9%2021
Up years2/7
2020-30.3%
2021-78.9%
2022-69.7%
2023-60.9%
2024+144.4%
2025-37.7%
2026+5.1%
2020 annual price return
-30.3%
2021 annual price return
-78.9%
2022 annual price return
-69.7%
2023 annual price return
-60.9%
2024 annual price return
+144.4%
2025 annual price return
-37.7%
2026 annual price return
+5.1%
LessMore
Alpha vs S&P 500
1Y-37.5%
3Y-45.5%
5Y-57.9%

Price returns only.

Download Historical Data

1,373 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

IKT Stock Price Trajectory (2020–2026)

As of June 12, 2026, Inhibikase Therapeutics, Inc. (IKT) trades at $1.67, representing a -14.8% return over the past year. The stock has delivered a -95.3% total return over five years (-45.8% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $70.80 on December 23, 2020. From this peak, IKT has corrected -97.6%, currently trading 2% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers PRTA (+62.0% 1Y), ACAD (-4.1% 1Y), and SAVA (-36.8% 1Y), IKT has underperformed the peer group average. Compare IKT vs PRTA →

IKT Historical Price Data · from 2020

Rows 1–50 of 1,373
Date Open High Low Close Volume Change %
2026-06-111.691.701.651.67323K+0.60%
2026-06-101.691.721.651.66634K-0.60%
2026-06-091.651.691.601.67783K+3.09%
2026-06-081.671.681.611.62603K-0.61%
2026-06-051.701.701.611.63620K-1.81%
2026-06-041.711.731.651.66421K-0.60%
2026-06-031.701.741.651.67843K-1.76%
2026-06-021.701.731.661.70520K-0.58%
2026-06-011.751.791.701.71516K-2.29%
2026-05-291.751.761.731.75285K-1.13%
2026-05-281.701.781.691.77420K+4.12%
2026-05-271.711.741.701.70494K0.00%
2026-05-261.711.751.691.70389K+0.59%
2026-05-221.731.781.691.69483K-2.87%
2026-05-211.651.771.631.74968K+3.57%
2026-05-201.591.701.571.68671K+7.01%
2026-05-191.581.601.531.571.37M-2.48%
2026-05-181.731.771.571.611.72M-6.94%
2026-05-151.841.841.721.73942K-6.99%
2026-05-141.911.931.831.86286K-2.11%
2026-05-131.891.951.871.90791K-1.04%
2026-05-122.012.041.921.92573K-5.42%
2026-05-112.082.132.022.03503K-1.46%
2026-05-081.982.101.952.06946K+3.52%
2026-05-072.002.041.911.99796K-1.00%
2026-05-061.952.011.902.01624K+4.15%
2026-05-051.971.991.911.93437K-0.52%
2026-05-041.911.991.891.94450K+1.57%
2026-05-011.871.911.831.91865K+1.06%
2026-04-301.871.941.861.89432K+1.61%
2026-04-291.861.891.831.86481K-1.06%
2026-04-281.891.901.841.88543K-0.53%
2026-04-271.861.921.851.89689K+0.53%
2026-04-241.921.951.861.88630K-2.59%
2026-04-231.821.951.781.93992K+6.04%
2026-04-221.701.821.661.82953K+8.98%
2026-04-211.791.791.631.672.58M-7.73%
2026-04-201.801.921.761.811.83M-1.09%
2026-04-171.731.851.721.831.55M+7.65%
2026-04-161.781.791.671.70838K-5.03%
2026-04-151.691.801.691.791.10M+5.29%
2026-04-141.731.751.691.701.37M-0.58%
2026-04-131.711.771.681.71814K+0.59%
2026-04-101.721.741.671.70863K+0.59%
2026-04-091.741.761.671.691.11M-2.87%
2026-04-081.831.831.721.74701K-1.14%
2026-04-071.801.801.691.76729K-1.68%
2026-04-061.801.821.751.79688K-0.56%
2026-04-021.751.831.741.80758K-0.55%
2026-04-011.711.831.701.811.16M+7.74%
…

What if you invested $1,000 in IKT 10 years ago?

Total return calculator · dividends reinvested

Calculate Returns

How much would $100/month in IKT be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is IKT Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

IKT vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

IKT — Frequently Asked Questions

Quick answers to the most common questions about buying IKT stock.

How has IKT stock performed recently?

IKT declined -14.8% over the past year, below its 5-year annualized CAGR of -45.8%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is IKT's all-time high price?

Inhibikase Therapeutics, Inc. reached $70.80 on 2020-12-23. The 52-week high is $2.26. Current 1-year return of -14.8% places the stock further from historical peaks.

Where can I download IKT historical price data?

This page provides IKT daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.

459 data points · sampled from 1,373